We use cookies to ensure that we give you the best experience on our website Learn more

Dec 3, 2017

International Diabetes Federation 2017 Congress

Trial-level comparisons of iGlarLixi versus IDegLira in the LixiLan and DUAL clinical development programmes

;

Blonde, L.;

Ritzel, R.;

Wysham, C.;

Frias, J.;

Rosenstock, J.

thumbnail

Keywords

Company

Legal

Follow us

© Copyright 2019 Morressier GmbH. All rights reserved.

© Copyright 2019 Morressier GmbH.
All rights reserved.